Product ID: UCMIG35A2495
Non-alcoholic Steatohepatitis Clinical Trials Market Size, Share, Growth Analysis, By Phase(Phase I, Phase II), By Study Design(Interventional, Observational), By Region(North America, Europe) - Industry Forecast 2024-2031
Report ID:
UCMIG35A2495 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
Non-alcoholic Steatohepatitis Clinical Trials Market Insights
Market Overview:
The global non-alcoholic steatohepatitis clinical trials market was assessed at USD 2.42 billion in 2021, with a compound annual growth rate (CAGR) of 6.5% anticipated from 2022 to 2030. Factors such as increasing drug R&D, rising obesity and diabetes prevalence due to sedentary lifestyles, & unmet medical requirements can all be related to the expansion. The COVID-19 pandemic, as well as the FDA's request for additional post-interim safety and efficacy data, have stalled the ultimate approval of a phase III trial investigating obeticholic acid for nonalcoholic steatohepatitis (NASH). The COVID-19 pandemic in 2020 highlighted the multiple vulnerabilities of people living with illnesses like diabetes and obesity. The greatest risk of COVID-19 is linked to NASH.
Non-alcoholic Steatohepatitis Clinical Trials Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
To get more reports on the above market click here to
Get Free Sample
Get Free Sample
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Non-alcoholic Steatohepatitis Clinical Trials Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
